InvestorsHub Logo
Followers 3
Posts 324
Boards Moderated 0
Alias Born 12/21/2022

Re: KRISGO post# 222

Thursday, 12/05/2024 9:27:00 AM

Thursday, December 05, 2024 9:27:00 AM

Post# of 242
Nothing really changed. Rolvedon doesn't look different from Neulasta and multiple biosimilars. Sales have remained flat over the last three quarters.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASRT News